CAR-T Medical Scientist (MS) – Kite | Ireland and Scotland

Location: United Kingdom - Edinburgh

Date posted: May 13, 2026

About the Opportunity

At Kite, we are focused on advancing cell therapy to help transform outcomes in blood cancer. As we expand our CAR‑T Medical Scientist team across Ireland and Scotland, this is an opportunity to play a visible role in CAR‑T treatments, while building trusted scientific partnerships and helping bring innovative treatment approaches to more patients.

What you will do

As a CAR‑T Medical Scientist, you will join a field‑based scientific team supporting a growing portfolio of blood cancer indications. You will work closely with clinicians across Ireland and Scotland, support medical activities in multiple indications including DLBCL, ALL, MCL and multiple myeloma (MM) and generate insights that help shape medical strategy in a fast‑evolving area of oncology. This is a high‑impact, customer‑facing field medical role suited to someone who enjoys scientific exchange, thrives in cross‑functional environments, and is motivated by the opportunity to contribute to the implementation of innovative therapies in clinical practice. Experience with xKAM ways of working would be an advantage.

Key responsibilities

• Scientific Engagement
  • Build trusted scientific relationships with stakeholders across the blood cancer CAR‑T pathway in Ireland and Scotland.
  • Deliver clear, balanced scientific information and disease education in DLBCL, MCL, ALL, and multiple myeloma.
  • Support advisory boards, educational programmes, scientific training, and regional projects within the allocated territory.
  • Partner with Commercial, Market Access, and Regulatory teams while maintaining the independence of Medical Affairs.
• Strategic Insight Generation
  • Capture meaningful clinical insights that help inform medical strategy.
  • Identify unmet needs, barriers to adoption, and evidence‑generation opportunities.
• Compliance and Ways of Working
  • Work within governance and Medical Affairs compliance frameworks.
  • Apply MS ways of working across all activities, with particular emphasis on xKAM.

What we are looking for

Experience and qualifications

• Previous experience working within a CAR‑T team is strongly preferred.
• Strong scientific understanding of haematology/oncology; experience in DLBCL and MM would be an advantage.
• An advanced scientific degree (PhD, PharmD, MD, or equivalent) is preferred.
• Previous MSL/MS field medical experience is preferred; launch experience in blood cancers would be particularly valuable.
• Confident interpreting and communicating complex scientific data, with strong critical appraisal skills.

Personal strengths

• Strong scientific communicator.
• Builds collaborative, trusted relationships.
• Insight‑driven with a strategic mindset.
• Proactive, organised, and adaptable.
• Works effectively both cross‑functionally and independently.

This is an opportunity to join a team working at the forefront of cell therapy, in a role that combines scientific depth, external engagement, and meaningful impact for patients. You will work in a fast‑moving environment, and help expand access to innovative treatment approaches in blood cancer.

Travel Requirements

This field‑based role requires regular travel across Ireland and Scotland for meetings with HCPs, as well as attendance at key UKI and international congresses. Overnight travel will be required, alongside occasional visits to the UKI affiliate head office in London. A full, clean driving licence is essential.

Equal Employment Opportunity (EEO)

It is the policy of Gilead Sciences, Inc. and its subsidiaries and affiliates (collectively "Gilead" or the "Company") to recruit select and employ the most qualified persons available for positions throughout the Company. Except if otherwise provided by applicable law, all employment actions relating to issues such as compensation, benefits, transfers, layoffs, returns from layoffs, company-sponsored training, education assistance, social and recreational programs are administered on a non‑discriminatory basis (i.e. without regard to protected characteristics or prohibited grounds, which may include an individual’s gender, race, color, national origin, ancestry, religion, creed, physical or mental disability, marital status, sexual orientation, medical condition, veteran status, and age, unless such protection is prohibited by federal, state, municipal, provincial, local or other applicable laws). Gilead also prohibits discrimination based on any other characteristics protected by applicable laws.